Metraipolis › archive › dc_35970f643b13

Second Primary Malignancy in Ixazomib Maintenance Therapy for Multiple Myeloma: Case Report and Literature Review — Europe PMC PMID:41306911

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41306911
DOI
10.1155/crh/6814237
License (as archived)
solo-consultazione
Archived
2026-11-08T11:26:37.108Z
SHA-256 of the archived text
5535a62baad4bc7e8d023aa7fa6321892eb71d69816bfcc2de40e2c8a1d57679
Stable URL of this page
https://metraipolis.com/documento/dc_35970f643b13

How to cite

Second Primary Malignancy in Ixazomib Maintenance Therapy for Multiple Myeloma: Case Report and Literature Review — Europe PMC PMID:41306911 — Europe PMC (en), https://europepmc.org/article/MED/41306911 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_35970f643b13 (Metraipolis archive dc_35970f643b13, sha256 5535a62baad4bc7e8d023aa7fa6321892eb71d69816bfcc2de40e2c8a1d57679)
BibTeX
@misc{dc35970f643b13,
  title = {Second Primary Malignancy in Ixazomib Maintenance Therapy for Multiple Myeloma: Case Report and Literature Review — Europe PMC PMID:41306911},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41306911},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_35970f643b13; sha256 5535a62baad4bc7e8d023aa7fa6321892eb71d69816bfcc2de40e2c8a1d57679},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41306911. Agents can read the archived copy with the MCP tool read_document.